Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Wednesday 02 January, 2013

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 7101U
GlaxoSmithKline PLC
02 January 2013
 



 

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

I give below details of changes in the Directors' interests in the Ordinary shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

 

On 31 December 2012, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary Shares and American Depositary Shares (ADSs) in the Company through the annual reinvestment of dividends paid throughout 2012:  

 

GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share Award - Annual Dividend Reinvestment

 

Non-Executive Director

No. of Ordinary Shares

Average Price (£)

No. of ADSs

Average Price ($)

Sir Christopher Gent

4,610.092

13.43

 

 

Prof Sir Roy Anderson

671.657

13.43

 

 

Dr Stephanie Burns

 

 

549.830

43.39

Ms Stacey Cartwright

67.351

13.43

 

 

Sir Crispin Davis

3,835.178

13.43

 

 

Ms Judy Lewent

 

 

        41.107

43.39

Sir Deryck Maughan

 

 

1,460.014

43.39

Dr Daniel Podolsky

 

 

971.294

43.39

Mr Tom de Swaan

993.381

        13.43

 

 

Sir Robert Wilson

1,609.456

        13.43

 

 

 

The Company and the Non-Executive Directors were informed of these allocations on 2 January 2013.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

V A Whyte

Company Secretary

2 January 2013


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQLLFBXFFZBBL

a d v e r t i s e m e n t